Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Orange

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Immunologic Research|August 20, 2017
Recycling endosomes in human cytotoxic T lymphocytes constitute an auxiliary intracellular trafficking pathway for newly synthesized perforinKelsey Lesteberg, Jordan Orange, George Makedonas
Molecular Immunology|February 14, 2017
Inducible turnover of optineurin regulates T cell activationAngela Montecalvo, Simon C Watkins, Jordan Orange, et al.
Immunologic Research|January 24, 2016
Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global NetworkVicki Modell, Jessica Quinn, Jordan Orange, et al.
Pediatrics|July 4, 2013
Immunologic features of Cornelia de Lange syndromeSoma Jyonouchi, Jordan Orange, Kathleen E Sullivan, et al.
Immunologic Research|February 23, 2017
Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurementVicki Modell, Jessica Quinn, Grant Ginsberg, et al.
Journal of Patient Experience|January 18, 2021
Relationship-Centered Care in a Novel Dual-Visit Model COVID Nursery Follow-Up ClinicMinna Saslaw, Melissa E Glassman, M Kathleen Keown, et al.
Immunologic Research|March 27, 2014
Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discoveryVicki Modell, Megan Knaus, Fred Modell, et al.
Immunologic Research|May 29, 2020
Jeffrey's insights: Jeffrey Modell Foundation's global genetic sequencing pilot program to identify specific primary immunodeficiency defects to optimize disease management and treatmentJessica Quinn, Vicki Modell, Jennifer Holle, et al.
Immunotherapy|May 9, 2023
Development of a novel shared decision making aid for primary immunodeficiency diseasesSpiros Tzivelekis, Jordan Orange, Christine Poulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2013
Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAKHong-Ying Wang, Chi A Ma, Yongge Zhao, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Immunologic Research|August 20, 2017
Recycling endosomes in human cytotoxic T lymphocytes constitute an auxiliary intracellular trafficking pathway for newly synthesized perforinKelsey Lesteberg, Jordan Orange, George Makedonas
Molecular Immunology|February 14, 2017
Inducible turnover of optineurin regulates T cell activationAngela Montecalvo, Simon C Watkins, Jordan Orange, et al.
Immunologic Research|January 24, 2016
Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global NetworkVicki Modell, Jessica Quinn, Jordan Orange, et al.
Pediatrics|July 4, 2013
Immunologic features of Cornelia de Lange syndromeSoma Jyonouchi, Jordan Orange, Kathleen E Sullivan, et al.
Immunologic Research|February 23, 2017
Modeling strategy to identify patients with primary immunodeficiency utilizing risk management and outcome measurementVicki Modell, Jessica Quinn, Grant Ginsberg, et al.
Journal of Patient Experience|January 18, 2021
Relationship-Centered Care in a Novel Dual-Visit Model COVID Nursery Follow-Up ClinicMinna Saslaw, Melissa E Glassman, M Kathleen Keown, et al.
Immunologic Research|March 27, 2014
Global overview of primary immunodeficiencies: a report from Jeffrey Modell Centers worldwide focused on diagnosis, treatment, and discoveryVicki Modell, Megan Knaus, Fred Modell, et al.
Immunologic Research|May 29, 2020
Jeffrey's insights: Jeffrey Modell Foundation's global genetic sequencing pilot program to identify specific primary immunodeficiency defects to optimize disease management and treatmentJessica Quinn, Vicki Modell, Jennifer Holle, et al.
Immunotherapy|May 9, 2023
Development of a novel shared decision making aid for primary immunodeficiency diseasesSpiros Tzivelekis, Jordan Orange, Christine Poulos, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2013
Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAKHong-Ying Wang, Chi A Ma, Yongge Zhao, et al.
Pageof 2